earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Churchill Downs Incorporated, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.5 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about GoodRx
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Churchill Downs Incorporated, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.5 in the same window. Source depth averages 3 original sources per story, versus 2.7 across the same-window beat baseline. We currently track 1 AI story that mention GoodRx, all published on February 26, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 44 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering GoodRx. Shared-story counts are live from our verified record — not editorial picks.
Schrödinger and GoodRx reported full-year 2025 results, demonstrating the growing financial impact of AI-driven computational platforms in drug discovery and healthcare. These reports, alongside Churchill Downs' record performance, highlight a broader trend of data-centric companies leveraging machine learning to optimize specialized market verticals.
GoodRx is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.